GlassScriptPhysician profile
Thomas R Dowd
NPI 1164425849
$1,269.32
in general payments reported to CMS, 2019-2025
31 companies · $37.57 in 2025
The $37.57 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $159 · 2021: $235 · 2022: $184 · 2023: $97.06 · 2024: $147 · 2025: $37.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.24 | 2019-2023 | Qulipta |
| Amgen INC. | $92.43 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $86.85 | 2024-2025 | Eliquis |
| Intuitive Surgical, INC. | $76.39 | 2019 | |
| Amarin Pharma, INC. | $38.57 | 2020-2021 | |
| Evofem Biosciences, INC. | $31.51 | 2021 | |
| Pfizer INC. | $29.73 | 2022-2023 | |
| Astellas Pharma US INC | $28.33 | 2021-2024 | Veozah |
| Stryker Corporation | $28.03 | 2019 | |
| Medtronic, INC. | $27.48 | 2022 | |
| Exeltis, USA INC. | $26.98 | 2021-2022 | |
| Hologic Sales and Service, LLC | $26.71 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.07 | 2020 | |
| Boston Scientific Corporation | $25.35 | 2024 | Watchman Flx |
| Verity Pharmaceuticals INC. | $24.65 | 2024 | Tlando |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $23.37 | 2023 | Nexplanon |
| Therapeuticsmd, INC. | $22.84 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $22.83 | 2019 | |
| Allergan, INC. | $20.53 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.28 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.55 | 2019 | |
| Electromed, INC. | $16.43 | 2025 | Smartvest |
| Abbott Laboratories | $16.18 | 2024 | Freestyle Libre 3 |
| Avion Pharmaceuticals | $14.65 | 2021 | |
| Inspire Medical Systems, INC. | $14.26 | 2023 | Inspire |
| Sumitomo Pharma America, INC. | $13.76 | 2023 | Gemtesa |
| Lupin INC. | $12.74 | 2019 | |
| Esperion Therapeutics, INC. | $12.34 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.45 | 2021 | |
| Sanofi Pasteur INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dowd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.